Actively Recruiting
Retraining and Control Therapy ReACT for Adults with Psychogenic Non-Epileptic Seizures PNES to Improve Sense of Control and Reduce Symptom Expectations
Led by University of Alabama at Birmingham · Updated on 2026-06-11
50
Participants Needed
1
Research Sites
21 weeks
Total Duration
AI-Summary
What This Trial Is About
This research aims to evaluate Retraining and Control Therapy ReACT for adults aged 19 and older diagnosed with psychogenic non-epileptic seizures PNES, which are episodes resembling epileptic seizures but without epileptiform activity. The study focuses on improving sense of control and reducing catastrophic symptom expectations as treatment targets. Participants are treated at the UAB FND clinic and randomly assigned to different waiting periods before therapy begins. Participants receive 12 weekly telehealth sessions of ReACT, a cognitive behavioral therapy designed to help regain control over their body by managing thoughts and behaviors that reinforce PNES. Participants are randomized into one of three groups no waiting period, a 3-month waiting period, or a 6-month waiting period before starting therapy. The study involves baseline, treatment, and multiple follow-up assessments to measure therapy effects. Participants will complete a baseline visit involving questionnaires, cognitive tests, saliva collection for cortisol response, and sleep and PNES episode tracking with an Actiwatch. Follow-up assessments occur 7 days after the final therapy session and at 2, 6, and 12 months post-treatment. They will also keep diaries logging PNES frequency from 30 days before until 12 months after treatment. Researchers will measure sense of control, symptom expectations, PNES frequency, cognitive performance, mood, and quality of life throughout the study.
CONDITIONS
Brief Title
Retraining and Control Therapy (ReACT)- Adults
Research Team
A
Aaron Fobian, PhD
S
Stephanie Mueller, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here